|
| 36540980 | Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight Gain. | Pac Symp Biocomput | 2023 |
| 36098846 | Intimate Partner Violence and Engagement in the HIV Care Continuum among Women in Sub-Saharan Africa: A Prospective Cohort Study. | AIDS and Behavior | 2023 |
| 36348194 | Correction to: Intimate Partner Violence and Engagement in the HIV Care Continuum among Women in Sub-Saharan Africa: A Prospective Cohort Study. | AIDS and Behavior | 2023 |
| 37866010 | Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for quantifying lenacapavir plasma concentrations: Application to therapeutic monitoring. | | 2023 |
| 36763044 | Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy. | J Infect Dis | 2023 |
| 34240467 | Multicompartmental pharmacokinetic evaluation of long-acting cabotegravir in healthy adults for HIV preexposure prophylaxis. | British Journal of Clinical Pharmacology | 2022 |
| 35784676 | Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir. | Journal of Virus Eradication | 2022 |
| 36255254 | MTN-033: a Phase 1 Study Comparing Applicator versus "as Lubricant" Delivery of Rectal Dapivirine Gel. | Antimicrobial Agents and Chemotherapy | 2022 |
| 36713413 | Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated. | | 2022 |
| 32829410 | Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens. | Clin Infect Dis | 2021 |
| 33752534 | Likely clinical depression and HIV-related decline in antiretroviral therapy untreated women who seroconverted during participation in microbicide trials in sub-Saharan Africa. | International Journal of STD and AIDS | 2021 |
| 33901188 | Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults. | PLoS Genet | 2021 |
| 33450518 | Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes. | EBioMedicine | 2021 |
| 33043969 | Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1. | Clinical Infectious Diseases | 2021 |
| 32823274 | Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy. | J Infect Dis | 2021 |
| 31282542 | A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation. | Journal of Infectious Diseases | 2020 |
| 31634201 | T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy. | AIDS | 2020 |
| 33177477 | Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral Therapy. | Journal of acquired immune deficiency syndromes (1999) | 2020 |
| 31408030 | Social harms in female-initiated HIV prevention method research: state of the evidence. | AIDS | 2019 |
| 30346511 | Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring. | Clin Infect Dis | 2019 |
| 30759997 | Complex decisions: correlates of injectable contraceptive discontinuation following HIV-1 seroconversion in an HIV prevention trial. | AIDS Care | 2019 |
| 29847509 | Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. | Pharmacogenet Genomics | 2018 |
| 30364428 | Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART. | Open Forum Infect Dis | 2018 |
| 29370196 | Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults. | PLoS One | 2018 |
| 28658251 | HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial. | PLoS ONE | 2017 |
| 28692531 | Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy. | AIDS | 2017 |
| 28426825 | Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. | PLoS Pathog | 2017 |
| 28723708 | Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy. | AIDS | 2017 |
| 26333941 | Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy. | J Infect Dis | 2016 |
| 27090986 | Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials. | Clin Infect Dis | 2016 |
| 26866954 | Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis. | J Acquir Immune Defic Syndr | 2016 |
| 27465646 | Long-term follow-up of HIV seroconverters in microbicide trials - rationale, study design, and challenges in MTN-015. | | 2016 |
| 26647281 | Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells. | Journal of Infectious Diseases | 2016 |
| 25680424 | Factors associated with bone mineral density in healthy African women. | Arch Osteoporos | 2015 |
| 25073894 | HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy. | Clinical Infectious Diseases | 2014 |
| 24842909 | Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens. | Clin Infect Dis | 2014 |
| 23262497 | Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies. | AIDS | 2013 |
| 24046302 | Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis. | Clinical Infectious Diseases | 2013 |
| 23943825 | Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. | Clin Infect Dis | 2013 |
| 24297499 | Peripheral neuropathy in ART-experienced patients: prevalence and risk factors. | J Neurovirol | 2013 |
| 24144899 | Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142. | HIV Clin Trials | 2013 |
| 24005375 | CD4âºCD73⺠T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression. | AIDS | 2013 |
| 23055555 | Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. | J Virol | 2012 |
| 21857357 | Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study. | J Acquir Immune Defic Syndr | 2011 |
| 21350368 | Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase. | Journal of acquired immune deficiency syndromes (1999) | 2011 |
| 20871389 | European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142. | AIDS | 2011 |
| 21548986 | Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data. | Cost Effectiveness and Resource Allocation | 2011 |
| 21941167 | Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection | AIDS | 2011 |
| 21821798 | Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes. | J Immunol | 2011 |
| 20231689 | Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs. | J Immunol | 2010 |